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Abstract 
The suspensions of methanol and petroleum ether extracts of entire plant of Portulaca oleracea in carboxy methyl cellulose (CMC) were evaluated for 
hepatoprotective activity in Wister albino rats by inducing hepatic injury with D-galactosamine (400 mg/kg). D-galactosamine induced hepatic damage was 
manifested by a significant increase in the activities of marker enzymes. Biochemical data exhibited significant hepatoprotective activity of Methanol extract 
of Portulaca oleracea at oral dose of 200 and 400 mg/kg against D-galactosamine. Silymarin was used as reference standard also exhibited significant 
hepatoprotective activity against D-galactosamine. The biochemical observations were supplemented with histopathological examination of rat liver sections. 
Phytochemical analysis of both pet ether and methanol extracts of Portulaca oleracea was also carried out.  
Keywords: Portulaca oleracea; Silymarin; carboxy methyl cellulose; D-Galactosamine; hepatoprotective activity 
Resumen 
Las suspensiones de los extractos en methanol y eter de Portulaca oleracea (planta complete) en carboxi-metil celulosa (CMC) fueron evaluadas por su 
actividad protectora en ratas Wister albino contra el daño hepático inducido con D-Galactosamina. El daño causado por la D-Galactosamina se manifestó 
como un aumento significativo en la actividad de los marcadores enzimáticos. Los resultados bioquímicos mostraron un efecto protector importante del 
extracto metanólico de Portulaca oleracea contra dosis orales de 200 and 400 mg/kg de D-Galactosamina. La droga de referencia, silimarina, también mostró 
un efecto protector importante. Las observaciones bioquímicas fueron suplementadas con la evaluación histopatológica de secciones de hígado. Se efectuó un 
análisis fitoquímica de ambos extractos. 
Palabras Clave: Portulaca oleracea; silimarina; carboxi-metil celulosa; D-Galactosamina; actividad hepatoprotectora 
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INTRODUCTION 
Hepatitis is common disease in the world 
especially in the developing countries. Despite 
considerable progress in the treatment of liver 
diseases by oral hepatoprotective agents, search 
for newer drugs continues because the existing 
synthetic drugs have several limitations. Hence, 
there are many researchers of traditional 
medicines attempting to develop new drugs for 
hepatitis (Liu 1989).  
Portulaca oleracea L. ((Portulacaceae) is a 
warm-climate annual, it is known as Lonika in 
Sanskrit, Peddapayilikura in Telugu. The plant is 
succulent, herbaceous, erect or decumbent 
growing up to 30 cm height with cylindrical 
stem of 2-3 mm in diameter. P. oleracea used 
traditionally for alleviating pain and swelling 
(Okwuasaba et al., 1987). The entire plant is 
usually cut into small pieces and eaten with salt; 
applied topically to soothe skin (Ghazanfar 
1994). It also exhibits a wide range of 
pharmacological effects, including antibacterial 
(Zhang et al., 2002), analgesic, anti-
inflammatory (Chan et al., 2000), and skeletal 
muscle- relaxant activities (Parry et al., 1987; 
Parry et al., 1993). A bronchodilatory effect in 
asthmatic patients, skeletal muscle relaxant, and 
antifertility effect were also reported for P. 
oleracea (Elkhayat et al., 2008).  It is also 
consumed as a vegetable, widely sold in United 
Arab Emirates and Oman (Miller and Morris, 
1988) and has been reported to be rich in α-
linolenic acid and β-Carotene (Liu et al., 2000). 
In addition to flavonoids, coumarins (Awad, 
1994) and monoterpene glycoside (Sakai et al., 
1996), it also contains neither N-Trans-
feruloyltyramine (Mizutani et al., 1998), 
dopamine, dopa, high concentrations of 
noradrenaline (Feng et al., 1981), ferulic acid 
(Chen, 2000), adenosine (Meng et al., 1981) and 
portulene (Elkhayat et al., 2008). This plant 
species is also a popular remedy in Trinidad and 
Tobago for urinary problems, "cooling" and high 
cholesterol. 
The hepatoprotective activities of 
hydroalcoholic extract of stems and leaves of P. 
oleracea in rats treated with CCl4- (Elkhayat et 
al., 2008) or rifampicin (Kulkarni et al., 2007) 
were previously reported. The present study was 
designed to investigate the hepatoprotective 
activity of petroleum ether and methanol extract 
of P. oleracea against D-galactosamine induced 
hepatotoxicity in rats. 
MATERIAL AND METHODS 
Plant material 
 The whole plant of P.oleracea was 
collected from surrounding Tirumala hills, 
Tirupathi, Andhra Pradesh in the month of 
November. The plant was authenticated by 
comparing with the specimen by Dr. K. 
Madhava Setty, Department of Botany, Sri 
Venkateshwara University, Tirupathi, Andhra 
Pradesh. A specimen voucher (KVCP103) has 
been deposited in the herbarium of department 
of Pharmacognosy, Sri K.V. College of 
Pharmacy, Chickballapur, India. The plant was 
cut into small pieces and coarsely powdered. 
The coarse powder was passed through a No. 10 
mesh and used for extraction. 
Preparations of plant extracts 
The coarsely powdered plant material was 
extracted with petroleum ether and methanol by 
using Soxhlet apparatus sequentially. Both 
extracts were concentrated to dryness in vacuum 
using a rotary flash evaporator and yield of 
methanol and petroleum ether extracts were 3.13 
%w/w and 1.90 %w/w. Extracts were dried in a 
desiccator and preserved in refrigerated 
condition. Both petroleum ether and methanol 
extracts were suspended in 0.3 % CMC just 
before administration to rats. 
Preliminary phytochemical screening 
 A preliminary phytochemical screening for 
steroids, flavonoids, glycosides, tannins, 
phenolic compounds, proteins and carbohydrates 
were carried out using a standard procedure 
described by Kokate (1986).  
Animals 
Male albino rats of Wister strain weighing 
about 150-200 g of either sex were acclimatized 
to the experimental room temperature 23 ± 2 °C, 
controlled humidity conditions (50-55 %) and 12 
h light and 12 h dark cycle. They were caged 
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with a maximum of two animals in each 
polypropylene cage and were fed with standard 
food pellets (Kamadenu Enterprises, Bangalore) 
and water ad libitum. The study was conducted 
after obtaining ethical committee clearance from 
the institutional animal ethical committee of 
J.S.S. C P, J.S.S. College of Pharmacy, 
Ootacamund, Tamilnadu (India) No. 
IAEC/JSSCP/02/2004-2005. 
Acute toxicity studies 
Petroleum and methanol extracts of P. 
oleracea were studied for acute oral toxicity as 
per OECD (Organization for Economic 
Cooperation and development) guidelines No. 
423, (2000). The extract was devoid of any 
toxicity in rats when given in dose up to 2000 
mg/kg by oral route. Hence, for further studies 
200- 400 mg/kg doses of extract were used. 
Hepatoprotective activity 
Rats were randomly divided into seven 
groups of six animals each. Group I: Served as 
control and received CMC (1 ml/kg p.o.) for a 
period of days. Group II:  Received D-
galactosmaine (400 mg/kg, i.p.) on 14th day. 
Group III: Received silymarin (25 mg/kg p.o.) 
for 14 days and hepatotoxicant on  
 14th day intraperitonially. Group IV and V: 
Received petroleum ether extract P.  oleracea 
(200 and 400 mg/kg p.o.) for 14 days and 
hepatotoxicant on 14th day intraperitonially. 
Group VI and VII: Received methanol extract at 
dose P. oleracea (200 and 400 mg/kg  p.o.) for 
14 days and hepatotoxicant on 14th day 
intraperitonially.  
After 24 h of administration galactosamine, 
animals were anaesthetized with pentathol 
sodium. Blood was collected by Sino-orbital 
puncture, and rats were sacrificed after the 
collection of blood samples and the livers were 
excised immediately for histopathological 
examination. The blood samples were allowed to 
clot for 30-40 min. Serum was separated by 
centrifugation for 15- 20 min at 2000 rpm was 
used for estimation of various biochemical 
parameters (Deshpande, et al., 2003).   
Biological assays 
The activities of serum asparatate amino 
transferase (ASAT, GOT), alanine amino 
transferase (ALAT, GPT) (Reitaman and 
Frankel, 1957), alkaline phosphatase (ALP) 
(King and Armstrong, 1934), total bilirubin (TB) 
(Malloy and Evelyn, 1987), total cholesterol 
(TC), total protein (TP), albumin triglycerides 
(TGL) (Foster and Dunn, 1973) were carried 
out. 
Histopathology 
Small pieces of liver tissues were collected 
in 10% formal saline for proper fixation. These 
tissues were processed and embedded in paraffin 
wax. They were cut into section of 5 to 6 
microns in thickness were cut and stained with 
hematoxylin and eosin (Luna, 1966). 
Statistical analysis 
The data were expressed as mean ± S.E.M. 
The differences were compared using one-way 
ANOVA followed by Dunnett’s test using 
PRISM software (version 4). The results were 
considered significant when p<0.05. 
RESULTS 
Petroleum ether and methanolic extracts of 
P.oleracea showed the presence of alkaloids, 
flavonoids, steroids, saponins, fixed oils and 
tannins and phenolics. Table 1 showed effect of 
D-galactosmaine (group II) developed 
hepatocellular damage as evident from a 
significant elevation (P<0.01) in serum activities 
of AST, ALT, ALP, TGL, TP, Albumin and TB 
level when compared with control. The pet ether 
and methanolic extract of P. oleraceas showed 
significant restoration of the altered biochemical 
parameters (p<0.01 and p<0.05) at both the dose 
levels (200 and 400 mg/kg) when compared to 
d-galactosamine treated group. Silymarin also 
showed similar effect. 
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Figure 1. Histopathological observations. 
 
Group 1. Rats treated with CMC solvent showing structure of normal liver (H&E 400x). 
Group 2. Rats treated with D-galactosmaine showing 
severe periportal inflammation necrosis of zone1 
hepatocytes and bile duct hyperplasia (H&E 400x). 
Group 3. Rat treated with D-galactosmaine Silymarin 
showing focal necrosis and periprotal inflammation (H&E 
400x). 
 
Group 4. Rat treated with D-galactosmaine and 200 mg/kg 
of pet ether extract of  P. oleracea showing foamy 
degeneration of hepatocytes (H&E 400x). 
Group 5. Rat treated with D-galactosmaine and 200 mg of 
methanol extract of P.oleracea showing foamy 
degeneration of hepatocytes and regenerative activity 
(H&E 400x). 
Group 6. Rat treated with D-galactosmaine and 400 mg of 
pet ether extract of P. oleracea showing foamy 
degeneration of hepatocytes (H&E 400x). 
Group 7. Rat treated with D-galactosmaine and 400 mg of 
methanol extract of P. oleracea showing foamy
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Table 1. Effect of the petroleum ether and methanol extracts of P. oleracea on D-galactosmaine induced hepatotoxicity in rats. 
Sample  Solvent  D(+)galN Silymarin  Pet ether extract Methanol extract 
Dose 
(mg/kg) 
- 400 25 200 400 200 400 
TB 
(mg/dl) 
0.78±0.10 4.03±0.07 1.62±0.09** 3.43±0.19** 4.12±0.09** 2.8±0.07** 1.92±0.07** 
ASAT 
(U/L) 
28.33±1.48 73.33±3.40 31.83±2.02 68.83±2.81** 75.83±2.77** 37.67±3.18** 45.67±2.60** 
ALAT 
(U/L) 
18.83±0.60 84.83±3.44 23.17±0.95 74.67±1.89** 76.17±2.46** 38.40±1.36** 36±1.21** 
TGL 
(mg/dl) 
79.83±0.87 25.67±1.76 71.17±2.27* 31.5±2.14** 36.67±0.88** 69.67±1.89** 79.33±1.82 
TC (g/dl) 48.0±1.21 174±2.96 72.17±2.75** 172.83±4.21** 167.67±6.22** 106.67±5.94** 91.83±1.25** 
Albumin 
(g/dl) 
5.18±0.11 3.55±0.16 1.42±0.14** 3.23±0.15** 2.30±6.22** 6.37±0.11** 2.5±0.21** 
TP (g/dl) 9.90±0.15 5.35±0.40 8±0.12** 4.33±0.23** 4.38±0.31** 2.6±0.23** 7.43±0.17** 
ALP 197.68±6.82 373.33±17.7 215.17±6.46** 447.50±18.22** 415.83±4.32** 287.33±4.06** 244.33±5.28* 
Mean ± S.E.M.; (n=6); *P<0.05, **P<0.01 as compared with control (CMC) Dunnett’s test. TB: Total bilirubine. ASAT: asparatate amino 
transferase. ALAT: alanine amino transferase. TGL:  triglycerides. TC: Total cholesterol. TP: Total proteins. ALP: alkaline phosphatase
Histology of the liver sections of normal control 
animals (Group I) showed normal liver architecture 
The liver section of galactosmine treated (Group II) 
showed hepatic cells with severe toxicity 
characterized by inflammatory cell collection, 
scattered inflammation across liver parenchyma, 
focal necrosis and swelling up of vascular endothelial 
cells. Petroleum ether and methanol extracts of 
P.oleracea appeared to significantly prevent the 
galactosmine toxicity as revealed by the hepatic cells 
with well-preserved cellular architecture (Group III-
VII).  
DISCUSSION 
Galactosamine induced experimental model 
system in rats is recognized to be much like viral 
hepatitis in humans from both morphological and 
functional points of view (Keppler et al., 1968). 
Galactosamine has great liver specificity because 
hepatocytes have high levels of galactokinase and 
galactose-1-uridyltransferase. Galactosamine does 
not affect other organs (Maley et al., 1986 and 
Keppler et al., 1970). Galactosamine causes hepatic 
injury with spotty hepatocyte necrosis and marked 
portal and parenchymal infiltration (Keppler and 
Decker, 1969). Galactosamine also causes depletion 
of uridine diphosphate (UDP) by increasing the 
formation of UDP-sugar derivatives, which results in 
inhibition of RNA and protein synthesis leading to 
cell membrane deterioration (Decker et al., 1973; El-
Mofty et al., 1975).  
Galactosamine administration in rats disrupts the 
membrane permeability of the plasma membrane 
causing leakage of the enzymes from the cell, which 
leads to elevation in levels of serum enzymes (Mitra 
et al., 2000). Elevated serum enzymes are indicative 
of cellular leakage and loss of functional integrity of 
the cell membrane in liver (Drotman and Lawhorn, 
1978). Hence significant rise in the transaminase 
levels could be taken as an index of liver damage. 
Further, intense galactosamination of membrane 
structure is thought to be responsible for loss of 
activity of ionic pumps. The impairment in the 
calcium pump, with consequent increase in the 
intracellular calcium is considered to be responsible 
for cell death (Tsai et al., 1997). The rise in ALAT 
activity is almost always due to hepatocellular 
damage and is usually accompanied by rise in ASAT 
(Rao et al., 1989). An increase in ALP reflects the 
pathological alteration in biliary flow (Plaa and 
Hewitt, 1989). Determination of serum bilirubin 
represents an index for the assessment of hepatic 
function and any abnormal increase in the levels of 
bilirubin in the serum indicate hepatobiliary disease 
and server disturbance of hepatocellular function 
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(Martin and Friedman, 1992). Increased levels of 
bilirubin in this study are in agreement with previous 
reports showing that d-GalN induced hepatitis is 
characterized by increased levels of bilirubin in 
serum (Sree Ramamurthy and Srinivasan, 1993; 
Maezona et al., 1996).The extract-mediated 
suppression of the increased bilirubin level suggests 
the possibility of the extract being able to stabilize 
biliary dysfunction. Hepatocellular damage due to 
alcohol, virus and drug induced hepatitis causes a 
modest hypertriglyceridemia (Glickman and Sebesin, 
1982) which is due to the biochemical changes 
inferring with the transport of triglycerides out of 
liver. Our study also showed an increased 
accumulation of triglycerides in D (+) galactosamine 
induced rats, which is in agreement with previous 
reports (Koff et al., 1971; Cartwright et al., 1982). 
Pre treatment with methanol extract of P. oleracea 
and Silymarin for 14 days protected the rat livers 
from D-galactosamine induced histopathological 
changes.  
CONCLUSION 
The results suggest that extracts from P. 
oleracea possess significant protection against 
galactosamine induced hepatotoxicity in rats.  
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